Pathophysiology of Schizophrenia Flashcards
Mesolimbic dopamine
Overactive mesolimbic dopamine circuits bring positive symptoms of schizophrenia
Effects of dopamine agonists/antagonists
Decrease positive symptoms
L-Dopa is a major one
Consequences of long-term drug treatment of positive symptoms
Medications for schizophrenia reduce dopamine transmission
Parkinsonian symptoms
Tardive dyskinesia (unable to stop moving)
Mesocortical dopamine
Mesocortical pathway ends in frontal cortex
Decreased activity of the dorsolateral prefrontal cortex (dlPFC) brings negative symptoms
dlPFC may also impact positive symptoms indirectly
Mediated by DISC1 gene during development
Glutamate hypothesis
PCP and ketamine decrease dopamine activity by reducing glutamate
Reduce dopamine activity of frontal lobes, increase in positive, negative, and cognitive symptoms